Intranasal application of xenon reduces opioid requirement and postoperative pain in patients undergoing major abdominal surgery: A randomized controlled trial

Anesthesiology

Volumn 115, Issue 2, 2011, Pages 398-407

  Holsträter, Thorsten Frederik ^a   Georgieff, Michael ^b   Föhr, Karl Josef ^b   Klingler, Werner ^b   Uhl, Miriam Elisabeth ^b   Walker, Tobias ^c   Köster, Sarah ^d   Grön, Georg ^b   Adolph, Oliver ^b  

^a BUNDESWEHRKRANKENHAUS ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; PLACEBO; REMIFENTANIL; XENON;

ABDOMINAL HYSTERECTOMY; ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LOW DRUG DOSE; NAUSEA; NOCICEPTION; OUTCOME ASSESSMENT; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 79961025162     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318225cee5     Document Type: Article

References (60)

1. Adolph O, Köster S, Georgieff M, Bäder S, Föhr KJ, Kammer T, Herrnberger B, Grön G: Xenon-induced changes in CNS sensitization to pain. Neuroimage 2010;49:720-30
2. Benrath J, Kempf C, Georgieff M, Sandkühler J: Xenon blocks the induction of synaptic long-term potentiation in pain pathways in the rat spinal cord in vivo. Anesth Analg 2007;104:106-11 (Pubitemid 46360430)
3. Sandkühler J: Understanding LTP in pain pathways. Mol Pain 2007;3:9
4. Bell RF, Dahl JB, Moore RA, Kalso E: Peri-operative ketamine for acute post-operative pain: A quantitative and qualitative systematic review (Cochrane review). Acta Anaesthesiol Scand 2005;49:1405-28 (Pubitemid 41565020)
5. Helmy SA, Bali A: The effect of the preemptive use of the NMDA receptor antagonist dextromethorphan on postoperative analgesic requirements. Anesth Analg 2001;92:739-44 (Pubitemid 32185121)
6. Weinbroum AA: A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg 2003;96:789-95 (Pubitemid 36245571)
7. Subramaniam K, Subramaniam B, Steinbrook RA: Ketamine as adjuvant analgesic to opioids: A quantitative and qualitative systematic review. Anesth Analg 2004;99:482-95 (Pubitemid 38970424)
8. Sanders RD, Franks NP, Maze M: Xenon: No stranger to anaesthesia. Br J Anaesth 2003;91:709-17 (Pubitemid 37369533)
9. Cullen SC, Gross EG: The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951;113:580-2
10. Lachmann B, Armbruster S, Schairer W, Landstra M, Trouwborst A, Van Daal GJ, Kusuma A, Erdmann W: Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet 1990;335:1413-5 (Pubitemid 20186433)
11. Derwall M, Coburn M, Rex S, Hein M, Rossaint R, Fries M: Xenon: Recent developments and future perspectives. Minerva Anesthesiol 2009;75:37-45
12. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W: Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. ANESTHESIOLOGY 2006;105:187-97 (Pubitemid 44305208)
13. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR: How does xenon produce anaesthesia? Nature 1998;396:324 (Pubitemid 28557385)
14. Salmi E, Laitio RM, Aalto S, Maksimow AT, Långsjo JW, Kaisti KK, Aantaa R, Oikonen V, Metsahonkala L, Någren K, Korpi ER, Scheinin H: Xenon does not affect gamma-aminobutyric acid type A receptor binding in humans. Anesth Analg 2008;106:129-34
15. Bantel C, Maze M, Trapp S: Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener. ANESTHESIOLOGY 2010;112:623-30
16. Dinse A, Fohr KJ, Georgieff M, Beyer C, Bulling A, Weigt HU: Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones. Br J Anaesth 2005;94:479-85
17. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP: Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004;65:443-52 (Pubitemid 38134273)
18. Bantel C, Maze M, Trapp S: Neuronal preconditioning by inhalational anesthetics: Evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. ANESTHESIOLOGY 2009;110:986-95
19. Hussain MA, Aungst BJ, Kapil R, Mousa SA: Intranasal absorption of the platelet glycoprotein IIb/IIIa receptor antagonist, DMP 755, and the effect of anesthesia on nasal bioavailability. J Pharm Sci 1997;86:1358-60
20. Illum L: Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 2004;56:3-17 (Pubitemid 38195323)
21. Mathias NR, Hussain MA: Non-invasive systemic drug delivery: Developability considerations for alternate routes of administration. J Pharm Sci 2010;99:1-20
22. Froeba G, Georgieff M, Linder EM, Föhr KJ, Weigt HU, Holsträter TF, Kölle MA, Adolph O: Intranasal application of xenon: Describing the pharmacokinetics in experimental animals and the increased pain tolerance within a placebocontrolled experimental human study. Br J Anaesth 2010;104:351-8
23. Apfelbaum JL, Chen C, Mehta SS, Gan TJ: Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534-40 (Pubitemid 36899761)
24. Breivik H, Stubhaug A: Management of acute postoperative pain: Still a long way to go!. Pain 2008;137:233-4
25. Kehlet H, Holte K: Effect of postoperative analgesia on surgical outcome. Br J Anaesth 2001;87:62-72 (Pubitemid 32631676)
26. Pöpping DM, Zahn PK, Van Aken HK, Dasch B, Boche R, Pogatzki-Zahn EM: Effectiveness and safety of postoperative pain management: A survey of 18 925 consecutive patients between 1998 and 2006 (2nd revision): A database analysis of prospectively raised data. Br J Anaesth 2008;101:832-40
27. Lemmens HJ, Bovill JG, Hennis PJ, Gladines MP, Burm AG: Alcohol consumption alters the pharmacodynamics of alfentanil. ANESTHESIOLOGY 1989;71:669-74 (Pubitemid 19275086)
28. Luginbühl M, Petersen-Felix S, Zbinden AM, Schnider TW: Xenon does not reduce opioid requirement for orthopedic surgery. Can J Anaesth 2005;52:38-44 (Pubitemid 40361017)
29. Fahlenkamp AV, Peters D, Biener IA, Billoet C, Apfel CC, Rossaint R, Coburn M: Evaluation of bispectral index and auditory evoked potentials for hypnotic depth monitoring during balanced xenon anaesthesia compared with sevoflurane. Br J Anaesth 2010;105:334-41
30. Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, Kvarstein G, Stubhaug A: Assessment of pain. Br J Anaesth 2008;101:17-24 (Pubitemid 351881909)
31. Currie SR, Wilson KG, Gauthier ST: Caffeine and chronic low back pain. Clin J Pain 1995;11:214-9
32. Rossaint R, Reyle-Hahn M, Schulte Am Esch J, Scholz J, Scherpereel P, Vallet B, Giunta F, Del Turco M, Erdmann W, Tenbrinck R, Hammerle AF, Nagele P, Xenon Study Group: Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. ANESTHESIOLOGY 2003;98:6-13 (Pubitemid 36043402)
33. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, Schwam EM, Siegel JL: Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: Study with intravenous midazolam. J Clin Psychopharmacol 1990;10:244-51 (Pubitemid 20319177)
34. Nalos M, Wachter U, Pittner A, Georgieff M, Radermacher P, Froeba G: Arterial and mixed venous xenon blood concentrations in pigs during wash-in of inhalational anaesthesia. Br J Anaesth 2001;87:497-8 (Pubitemid 32827490)
35. Yagi M, Mashimo T, Kawaguchi T, Yoshiya I: Analgesic and hypnotic effects of subanaesthetic concentrations of xenon in human volunteers: Comparison with nitrous oxide. Br J Anaesth 1995;74:670-3
36. Petersen-Felix S, Luginbühl M, Schnider TW, Curatolo M, Arendt-Nielsen L, Zbinden AM: Comparison of the analgesic potency of xenon and nitrous oxide in humans evaluated by experimental pain. Br J Anaesth 1998;81:742-7 (Pubitemid 28499936)
37. Nakata Y, Goto T, Saito H, Ishiguro Y, Terui K, Kawakami H, Tsuruta Y, Niimi Y, Morita S: Plasma concentration of fentanyl with xenon to block somatic and hemodynamic responses to surgical incision. ANESTHESIOLOGY 2000;92:1043-8 (Pubitemid 30180981)
38. Abt K: Planning controlled clinical trials on the basis of descriptive data analysis. Stat Med 1991;10:777-95
39. Coburn M, Kunitz O, Apfel CC, Hein M, Fries M, Rossaint R: Incidence of postoperative nausea and emetic episodes after xenon anaesthesia compared with propofol-based anaesthesia. Br J Anaesth 2008;100:787-91 (Pubitemid 351774322)
40. Weigt HU, Georgieff M, Beyer C, Wachter U, Föhr KJ: Xenon incorporated in a lipid emulsion inhibits NMDA receptor channels. Acta Anaesthesiol Scand 2003;47:1119-24 (Pubitemid 37108503)
41. McCartney CJ, Sinha A, Katz J: A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia. Anesth Analg 2004;98:1385-400 (Pubitemid 38525598)
42. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM: Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58 (Pubitemid 33016608)
43. Cepeda MS, Africano JM, Polo R, Alcala R, Carr DB: What decline in pain intensity is meaningful to patients with acute pain? Pain 2003;105:151-7 (Pubitemid 37162484)
44. Beers R, Camporesi E: Remifentanil update: Clinical science and utility. CNS Drugs 2004;18:1085-104 (Pubitemid 40007492)
45. Punjasawadwong Y, Boonjeungmonkol N, Phongchiewboon A: Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev 2007;17:CD003843
46. Barakat AR, Schreiber MN, Flaschar J, Georgieff M, Schraag S: The effective concentration 50 (EC50) for propofol with 70% xenon versus 70% nitrous oxide. Anesth Analg 2008;106:823-9 (Pubitemid 351301402)
47. Abramo A, Di Salvo C, Foltran F, Forfori F, Anselmino M, Giunta F: Xenon anesthesia improves respiratory gas exchanges in morbidly obese patients. J Obes 2010; Article ID 421593
48. Goto T, Saito H, Nakata Y, Uezono S, Ichinose F, Morita S: Emergence times from xenon anaesthesia are independent of the duration of anaesthesia. Br J Anaesth 1997;79:595-9 (Pubitemid 27493668)
49. Kissin I: Preemptive analgesia at the crossroad. Anesth Analg 2005;100:754-6 (Pubitemid 40300074)
50. Laulin JP, Maurette P, Corcuff JB, Rivat C, Chauvin M, Simonnet G: The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 2002;94:1263-9 (Pubitemid 34441848)
51. Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions. Pain 1995;62:259-74
52. Albrecht S, Fechner J, Geisslinger G, Maass AB, Upadhyaya B, Moecke H, Haigh C, Schüttler J: Postoperative pain control following remifentanil-based anaesthesia for major abdominal surgery. Anaesthesia 2000;55:315-22 (Pubitemid 30209448)
53. Bürkle H, Dunbar S, Van Aken H: Remifentanil: A novel, short-acting, mu-opioid. Anesth Analg 1996;83:646-51
54. Fletcher D, Pinaud M, Scherpereel P, Clyti N, Chauvin M: The efficacy of intravenous 0.15 versus 0.25 mg/kg intraoperative morphine for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery. Anesth Analg 2000;90:666-71 (Pubitemid 30117529)
55. Yarmush J, D'Angelo R, Kirkhart B, O'Leary C, Pitts MC 2nd, Graf G, Sebel P, Watkins WD, Miguel R, Streisand J, Maysick LK, Vujic D: A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. ANESTHESIOLOGY 1997;87:235-43 (Pubitemid 27435364)
56. Guntz E, Dumont H, Roussel C, Gall D, Dufrasne F, Cuvelier L, Blum D, Schiffmann SN, Sosnowski M: Effects of remifentanil on N-methyl-D-aspartate receptor: An electrophysiologic study in rat spinal cord. ANESTHESIOLOGY 2005;102:1235-41 (Pubitemid 40745843)
57. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M: Shortterm infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003;106:49-57 (Pubitemid 37329613)
58. Hood DD, Curry R, Eisenach JC: Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 2003;97:810-5 (Pubitemid 37046451)
59. Luginbühl M, Gerber A, Schnider TW, Petersen-Felix S, Arendt-Nielsen L, Curatolo M: Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg 2003;96:726-32 (Pubitemid 36245560)
60. Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother 2010;1:100-7